Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Nessn Azawi1,2, Mette Holm3, Jon Røikjær Henriksen4

  • 1Urologisk Afdeling, Sjællands Universitetshospital, Roskilde.

Ugeskrift for Laeger
|April 14, 2023
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Progression risk among responders to PD-1/PD-L1 blockade is primarily stratified by response depth: A nationwide cohort study of 2127 patients with melanoma, RCC, and NSCLC.

European journal of cancer (Oxford, England : 1990)·2026
Same author

DaRenCa risk score: A prognostic model for recurrence in clear cell renal cell carcinoma.

BJUI compass·2026
Same author

[Late sequelae after major urological surgery].

Ugeskrift for laeger·2026
Same author

Management of Lymph Node-Positive Renal Cell Carcinoma: Updated Recommendations from the European Association of Urology Renal Cell Carcinoma Guidelines Panel.

European urology·2026
Same author

[Contrast-induced acute kidney injury after prostatic artery embolization].

Ugeskrift for laeger·2026
Same author

Plasma and urine biomarker algorithm versus systematic biopsy for prostate cancer detection in elderly men: a randomised trial with early termination for futility.

Scandinavian journal of urology·2026
Same journal

[Mosaicism as a cause of Cowden syndrome].

Ugeskrift for laeger·2026
Same journal

[Thyrotoxic crisis with cardiogenic shock].

Ugeskrift for laeger·2026
Same journal

[Mindfulness-based cognitive therapy in the treatment of depression].

Ugeskrift for laeger·2026
Same journal

[Fitness].

Ugeskrift for laeger·2026
Same journal

[Risk of developing cataract related to fluoroscopy].

Ugeskrift for laeger·2026
Same journal

[Obturator hernia with small bowel ileus presenting as hip pain in an elderly woman].

Ugeskrift for laeger·2026
See all related articles

Each year, about 1,000 Danish patients are diagnosed with kidney cancer (renal cell carcinoma), with 20% presenting with metastatic disease. Advances in diagnosis and treatment have improved survival, but further research is needed.

Area of Science:

  • Urology
  • Oncology
  • Nephrology

Context:

  • Renal cell carcinoma (kidney cancer) affects approximately 1,000 patients annually in Denmark.
  • A significant 20% of diagnoses occur at the metastatic stage, highlighting a critical clinical challenge.

Purpose:

  • To review current diagnostic and therapeutic strategies for renal cell carcinoma.
  • To highlight recent advancements and identify areas for future research in kidney cancer management.

Summary:

  • Diagnostic imaging and renal mass biopsies enhance the accuracy of kidney cancer diagnosis.
  • Nephron-sparing surgery, robotic/laparoscopic approaches, and ablation therapy have become standard, improving patient recovery.
  • Tyrosine kinase inhibitors and immunotherapy have significantly extended survival over the past decade.

Related Experiment Videos

Impact:

  • Current diagnostic and treatment modalities have improved patient outcomes for renal cell carcinoma.
  • Despite progress, ongoing research is essential to further enhance survival rates and treatment efficacy for kidney cancer patients.